Position in SYRE
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$30,782,624
+$16,842,131 QoQ
Shares Held
610,282
+43.4% QoQ
Ownership
0.703%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $1,920,933,361 across 79 Biotechnology names. SYRE ranks #21 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
186,388 | $144,010,824 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
228,915 | $102,219,704 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
259,731 | $77,132,315 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
224,330 | $74,224,067 | |
| 5 | INSM |
INSMED Inc
|
401,735 | $65,691,707 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,516,297 | $58,362,271 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
580,677 | $56,470,838 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,001,976 | $55,454,735 |
All Filings in SYRE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,782,624 | 610,282 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $13,940,493 | 425,534 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $6,777,107 | 404,362 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,683,069 | 246,030 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,969,694 | 246,030 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,763,918 | 247,591 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,088,050 | 105,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,468,550 | 105,000 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,982,650 | 105,000 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||